| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |